在阿尔茨海默病患者血液中的补充成分3和粉样β寡合物的随后相关变化
Kyu Hwan Shim1, Danyeong Kim1, Min Ju Kang2
1Department of Bionano Technology, Gachon University, Seongnam, Republic of Korea.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 27, 2024
概括
阿尔茨海默氏病 (AD) 与血补剂成分3 (C3) 和粉样蛋白β寡合化倾向 (AβOt) 的升高有关,这表明粉样蛋白病理的潜在防御机制.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
背景情况:
- 阿尔茨海默氏病 (AD) 病原体涉及补充级联,补充成分3 (C3) 是一个关键参与者.
- 周围血液中C3和粉样β (Aβ) 之间的关系仍然不完全理解.
研究的目的:
- 调查血C3,粉样β寡合化倾向 (AβOt) 和已确定的阿尔茨海默病 (AD) 生物标志物之间的关联.
- 探索这些血标志物与AD患者的认知功能和粉样质子辐射断层扫描 (PET) 成像的相关性.
主要方法:
- 在35名阿尔茨海默病患者和62名健康对照人群中量化了血C3和AβOt水平.
- 分析了与脑脊液 (CSF) 生物标志物 (Aβ42),认知评分和粉样蛋白PET状态的相关性.
主要成果:
- 血C3和AβOt与对照组相比,在AD患者中显著升高.
- 这两种标记物彼此之间呈现出微弱的正相关性,但与CSF Aβ42和认知表现有很强的负相关性.
- 在C3水平变化之前,AβOt和CSF Aβ42异常发生.
结论:
- 在AD中血C3升高与粉样蛋白病理有关,可能表明对Aβ清除的补偿性免疫反应.
- 对Aβ结合蛋白的进一步研究是有必要的,以阐明血液中的Aβ机制.
相关概念视频
Alzheimer's Disease: Overview
484
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
484
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


